# OnCo record late-effects (term). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/terms/late-effects/>
  a schema:DefinedTerm ;
  onco:kind "term" ;
  schema:identifier "late-effects" ;
  schema:name "Late effects and survivorship toxicity"@en ;
  schema:alternateName "late effects"@en, "late toxicity"@en, "late toxicities"@en, "long-term toxicity"@en, "long-term toxicities"@en, "long-term side effects"@en, "long-term effects"@en, "chronic toxicity"@en, "cumulative toxicity"@en, "cumulative dose"@en, "lifetime dose"@en, "infertility"@en, "gonadotoxicity"@en, "premature ovarian insufficiency"@en, "premature menopause"@en, "growth impairment"@en, "neurocognitive effects"@en, "neurocognitive decline"@en, "cognitive impairment"@en, "chemo brain"@en, "lymphoedema"@en, "lymphedema"@en, "xerostomia"@en, "dry mouth"@en, "osteoporosis"@en, "bone loss"@en, "osteonecrosis"@en, "osteonecrosis of the jaw"@en, "sexual dysfunction"@en, "childhood cancer survivors"@en, "childhood cancer survivor"@en, "cumulative doses"@en ;
  schema:description "Health problems appearing months or decades after treatment ends: heart damage, infertility, second cancers, lymphoedema, dry mouth, memory problems, weak bones. They matter most for children and young adults, who live longest with them."@en ;
  schema:url <https://onco.cc/terms/late-effects/> ;
  schema:dateModified "2026-09-09"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Late_effect> ;
  schema:citation <https://en.wikipedia.org/wiki/Late_effect>, <https://www.bowelcanceruk.org.uk/about-bowel-cancer/living-with-and-beyond-bowel-cancer/long-term-and-late-side-effects/>, <https://www.macmillan.org.uk/cancer-information-and-support/bowel-cancer/managing-bowel-changes-after-treatment>, <https://www.nice.org.uk/guidance/ng151/chapter/Recommendations>, <https://lymphoma-action.org.uk/information-and-support/side-effects-lymphoma-and-treatment/late-effects-lymphoma-treatment>, <https://doi.org/10.1056/NEJMoa1505949>, <https://doi.org/10.1001/jamainternmed.2015.1180> ;
  onco:related <https://onco.cc/terms/secondary-malignancy/>, <https://onco.cc/terms/cardiotoxicity/>, <https://onco.cc/terms/peripheral-neuropathy/>, <https://onco.cc/terms/de-escalation/>, <https://onco.cc/terms/aya-oncology/> ;
  onco:cancers <https://onco.cc/cancers/colorectal/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/follicular-lymphoma/>, <https://onco.cc/cancers/mantle-cell-lymphoma/>, <https://onco.cc/cancers/marginal-zone-lymphoma/>, <https://onco.cc/cancers/malt-lymphoma/>, <https://onco.cc/cancers/splenic-marginal-zone-lymphoma/>, <https://onco.cc/cancers/nodal-marginal-zone-lymphoma/>, <https://onco.cc/cancers/waldenstrom/>, <https://onco.cc/cancers/primary-mediastinal-b-cell-lymphoma/>, <https://onco.cc/cancers/burkitt-lymphoma/>, <https://onco.cc/cancers/hodgkin-lymphoma/>, <https://onco.cc/cancers/early-stage-classical-hodgkin-lymphoma/>, <https://onco.cc/cancers/advanced-stage-classical-hodgkin-lymphoma/>, <https://onco.cc/cancers/relapsed-refractory-hodgkin-lymphoma/>, <https://onco.cc/cancers/nodular-lymphocyte-predominant-hodgkin-lymphoma/>, <https://onco.cc/cancers/peripheral-t-cell-lymphoma/>, <https://onco.cc/cancers/angioimmunoblastic-t-cell-lymphoma/>, <https://onco.cc/cancers/cutaneous-t-cell-lymphoma/>, <https://onco.cc/cancers/sezary-syndrome/>, <https://onco.cc/cancers/primary-cns-lymphoma/> ;
  onco:sections <https://onco.cc/fronts/supportive-care/>, <https://onco.cc/fronts/rejuvenation/> ;
  onco:technologies <https://onco.cc/technologies/survivorship-care-plan/>, <https://onco.cc/technologies/fertility-preservation/>, <https://onco.cc/technologies/exercise-oncology/> .